ArticleInternational journal of experimental pathology2021

miR-381-3p attenuates doxorubicin resistance in human anaplastic thyroid carcinoma via targeting homeobox A9.

Yan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.